MCLAUGHLIN MELISSA enters ALNYLAM PHARMACEUTICALS, INC. with 13.35K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/7/2026ACC: 0001178670-26-000012
Officer· Chief Human Resources Officer
Since Mar 2026
13.35K
Baseline shares
100% direct
13.35K
Direct ownership
1 position
3.57K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned13.35K
Total
13.35K direct13.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.35K | Direct |
| Total | 13.35K | 13.35K direct |
Derivative Holdings1
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
3.57K
Shares owned
N/A
Exercise price
325.07
Expiration
—
Exercise window
—
Total
Underlying
3.57K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 325.07 | — | — | 3.57K | N/A |
| Total | 3.57K | 0.00 | ||||